20 (AIDX) Operating Expenses (2025 - 2026)
20 (AIDX) reported Operating Expenses of $1.5 million for Q1 2026, up 60.58% on a YoY basis from $937975.0 in Q1 2025, and up 60.58% quarter-over-quarter from $937975.0 in Q1 2025.
20 (AIDX) Operating Expenses (2025 - 2026) Analysis & Trends
20 has reported Operating Expenses for 2 years, with the latest figure at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 60.58% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (changed N/A YoY), and the FY2025 full-year result was $3.9 million, down 34.82% from the prior year.
- Operating Expenses for Q1 2026 stood at $1.5 million, up from $937975.0 in the prior quarter.
- The five-year high for Operating Expenses was $1.5 million in Q1 2026, with the low at $937975.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 3.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 822.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -668.50 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 495.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 380.30 Mn |
| 10 | 20 | - | - | 62,884.00 | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.51 Mn |
| Mar 31, 2025 | 937,975.00 |